Neuroscience
Old Enemy Might Help to Prevent Alzheimer’s
By GINA KOLATA
The New York Times
Published: March 8, 2010
Read the full article
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Alzheimer's Products
FromThe New York Times: Tests Show Promise for Early Diagnosis of Alzheimer’s By GINA KOLATA The New York Times Published: January 18, 2011 "Researchers report major advances on two vexing questions about Alzheimer’s: How do you know if someone who...
- Dilemma Of Ever Earlier Diagnosis Of Alzheimer's Disease
Gina Kolata has written a fine piece inThe New York Times: Early Tests for Alzheimer’s Pose Diagnosis Dilemma By GINA KOLATA The New York Times Published: December 17, 2010 "Since there is no treatment, doctors wonder if they should tell people, years...
- Alzheimer's: Impaired Beta-amyloid Clearance
From the NIH: Impaired clearance, not overproduction of toxic proteins, may underlie Alzheimer’s disease 09 December 2010 In Alzheimer's disease, a protein fragment called beta-amyloid accumulates at abnormally high levels in the brain. Now researchers...
- Alzheimer's Disease: Rethinking Things?
A very readable piece from Gina Kolata of the New York Times: Doubt on Tactic in Alzheimer’s Battle By GINA KOLATA The New York Times Published: August 18, 2010 "The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and...
Neuroscience
Alzheimer's Disease: A-beta and Immune System
Old Enemy Might Help to Prevent Alzheimer’s
By GINA KOLATA
The New York Times
Published: March 8, 2010
"Harvard researchers are taking a new look at beta amyloid, which was thought to be a chief villain in Alzheimer’s whose function was that of a waste product in the brain."
Read the full article
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Alzheimer's Products
FromThe New York Times: Tests Show Promise for Early Diagnosis of Alzheimer’s By GINA KOLATA The New York Times Published: January 18, 2011 "Researchers report major advances on two vexing questions about Alzheimer’s: How do you know if someone who...
- Dilemma Of Ever Earlier Diagnosis Of Alzheimer's Disease
Gina Kolata has written a fine piece inThe New York Times: Early Tests for Alzheimer’s Pose Diagnosis Dilemma By GINA KOLATA The New York Times Published: December 17, 2010 "Since there is no treatment, doctors wonder if they should tell people, years...
- Alzheimer's: Impaired Beta-amyloid Clearance
From the NIH: Impaired clearance, not overproduction of toxic proteins, may underlie Alzheimer’s disease 09 December 2010 In Alzheimer's disease, a protein fragment called beta-amyloid accumulates at abnormally high levels in the brain. Now researchers...
- Alzheimer's Disease: Rethinking Things?
A very readable piece from Gina Kolata of the New York Times: Doubt on Tactic in Alzheimer’s Battle By GINA KOLATA The New York Times Published: August 18, 2010 "The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and...